心力衰竭中的血尼普利辛:响应动态和临床关联依赖于免疫测试
Samantha S M Ling1, Shera Lilyanna1, Jenny P C Chong1
1Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore ,Singapore.
Clinical chemistry
|May 21, 2025
概括
新的测试结果显示,心力衰竭 (HF) 患者的血 neprilysin (NEP) 水平不同. 目前的测定显示HF中NEP增加,但新的测定显示NEP减少,影响临床关联和预后价值.
科学领域:
- 生物化学 生物化学
- 心脏病学 心脏病学
- 生物标志物发现发现
背景情况:
- 已发表的关于血 neprilysin (NEP) 度,反应动态和健康和心力衰竭 (HF) 的临床关联的研究结果显示出不一致.
- 需要澄清NEP在不同生理和病理状态下的行为.
研究的目的:
- 调查血NEP测量的差异及其在心力衰竭中的临床相关性.
- 为了比较一种新型的糖化敏感免疫试验 (NEPCVRI) 与现有的商业试验 (NEPPE,NEPELLA) 和活性试验 (NEPACT).
主要方法:
- 血NEP使用新型单克隆抗体三明治ELISA (NEPCVRI) 测量在对照组和HF患者中 (保存和减少喷射分数).
- 结果与商业免疫试验 (NEPPE,NEPELLA) 和度活动试验 (NEPACT) 相比较.
主要成果:
- NEPCVRI试验没有显示与NEPPE,NEPELLA或NEPACT的相关性,这些与彼此有很强的相关性.
- 在HF中,NEPCVRI的监管下降,而NEPPE,NEPELLA和NEPACT的监管上升.
- 与其他测试相比,NEPCVRI显示与临床变量和并发症的反向关系,并且缺乏死亡率或HF事件的预后价值.
结论:
- 血NEP测定在HF中显示出不同的结果,与NEPPE,NEPELLA和NEPACT相比,NEPCVRI显示了相反的趋势.
- 血NEP的异质性 (糖化/非糖化形式) 和抗体特异性可能解释了相互矛盾的研究数据.
- 良好的特征免疫测试对于在临床和生物背景下准确评估NEP至关重要.
相关概念视频
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inotropic Agents
479
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
479
01:22Heart Failure Drugs: Diuretics
312
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
312
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
76
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
76
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
40
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40